BIOV — Biovaxys Technology Share News
0.000.00%
Last trade - 00:00- CA$3.10m
- CA$3.22m
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000
Brief: Biovaxys Says Co And Horizon Technology Finance Corp Execute Amendment To Asset Purchase Agreement
Brief: BioVaxys And Sona Nanotech Enter Research Collaboration
Brief: Biovaxys And Sona Nanotech Enter Research Collaboration
Brief: BioVaxys And SpayVac-For-Wildlife Expand License Agreement Into Commercial Aquaculture
Brief: Biovaxys Announces Upsizing Of Private Placement
Brief: BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases
Brief: Biovaxys Technology Will Experience Short Term Delay In Filing Its Audited Annual Financial Statements For Year Ended October 31, 2023
Brief: Biovaxys Announces Appointment Of CFO And Board Changes
Brief: Biovaxys Announces Appointment Of CFO And Board Changes
Brief: Biovaxys Announces Appointment Of CFO And Board Changes
Brief: Biovaxys Technology Announces Completed Debt Settlement
Brief: Biovaxys Announces Non-Brokered Private Placement Of Up To 10 Million Units
Brief: Biovaxys Technology Corp - International Patent Application Filed For Cervical Cancer Vaccine
Brief: BioVaxys Reports Appointment To Board Of Directors